4- (2, 6-dichlorobenzoylamino) - lH-pyrazole-3 -carboxylic acid piperidin4 -ylamid acid addition salts as kinase inhibitors

Details for Australian Patent Application No. 2006207323 (hide)

Owner Astex Therapeutics Limited

Inventors Rees, David Charles; Wyatt, Paul Graham; Trewartha, Gary; Vinkovic, Mladen

Agent Davies Collison Cave

Pub. Number AU-B-2006207323

PCT Pub. Number WO2006/077426

Priority 0501475.8 22.01.05 GB; 60/645,973 21.01.05 US

Filing date 20 January 2006

Wipo publication date 27 July 2006

Acceptance publication date 7 June 2012

International Classifications

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/4155 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/454 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

A61P 35/02 (2006.01) Antineoplastic agents

Event Publications

2 August 2007 PCT application entered the National Phase

  PCT publication WO2006/077426 Priority application(s): WO2006/077426

7 June 2012 Application Accepted

  Published as AU-B-2006207323

4 October 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006207325-Pharmaceutical compounds

2006207322-Combinations of pyrazole kinase inhibitors and further antitumor agents